267875-54-7 Usage
Uses
Used in Organic Synthesis:
Benzonitrile, 3-acetyl-4-fluoro(9CI) is used as a building block in the synthesis of various organic compounds. Its unique functional groups, acetyl and fluoro, allow for a range of chemical reactions and modifications, making it a versatile component in the creation of new molecules.
Used in Research and Development:
Benzonitrile, 3-acetyl-4-fluoro(9CI) serves as a research tool in the study of chemical reactions and mechanisms. Its distinct properties and reactivity can provide valuable insights into the behavior of similar compounds and contribute to the advancement of chemical knowledge.
Used in Pharmaceutical Industry:
Benzonitrile, 3-acetyl-4-fluoro(9CI) may be utilized in the development of pharmaceuticals, as its structural features can be incorporated into drug molecules to enhance their efficacy, selectivity, or stability. Its use in this industry can lead to the discovery of new therapeutic agents and improve existing treatments.
Used in Chemical Production:
Benzonitrile, 3-acetyl-4-fluoro(9CI) can be employed in the production of various chemicals, including agrochemicals, dyes, and other specialty chemicals. Its unique properties and reactivity make it a valuable intermediate in the synthesis of these products, contributing to the diversity and functionality of the chemical market.
Check Digit Verification of cas no
The CAS Registry Mumber 267875-54-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,7,8,7 and 5 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 267875-54:
(8*2)+(7*6)+(6*7)+(5*8)+(4*7)+(3*5)+(2*5)+(1*4)=197
197 % 10 = 7
So 267875-54-7 is a valid CAS Registry Number.
267875-54-7Relevant academic research and scientific papers
Thrombin inhibitors
-
, (2008/06/13)
Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure: or a pharmaceutically acceptable salt thereof, wherein b is NY or O; c is CY2or N; d is CY3or N; e is CY4or N; f is CY5or N; g is CY6or N; Y4, Y5, and Y6are independently hydrogen, C1-4alkyl, or halogen; Y1and Y2are independently hydrogen, C1-4alkyl, C3-7cycloalkyl, halogen, NH2, OH or C1-4alkoxy, and Y3is hydrogen, C1-4alkyl, C3-7cycloalkyl, halogen, —CN, NH2, OH or C1-4alkoxy; A is and W, W1, R1, R3, R4, R5, X and Z are defined in the specification.
